Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice

INTRODUCTION: Tumor Treating Fields (TTFields; antimitotic treatment) delivers low-intensity, intermediate-frequency, alternating electric fields through skin-applied transducer arrays. TTFields (200 kHz) was FDA-approved in glioblastoma (GBM), based on the phase 3 EF-11 (recurrent GBM, rGBM) and EF...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wenyin, Blumenthal, Deborah T., Oberheim Bush, Nancy Ann, Kebir, Sied, Lukas, Rimas V., Muragaki, Yoshihiro, Zhu, Jay-Jiguang, Glas, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438370/
https://www.ncbi.nlm.nih.gov/pubmed/32535723
http://dx.doi.org/10.1007/s11060-020-03540-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438370/
https://www.ncbi.nlm.nih.gov/pubmed/32535723
http://dx.doi.org/10.1007/s11060-020-03540-6

Ejemplares similares